News from relmada therapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Feb 02, 2016, 08:00 ET
Relmada Therapeutics Corporate Logo

Relmada Therapeutics to Present at the 18th Annual BIO CEO & Investor Conference

Relmada Therapeutics, Inc. (OTCQB: RLMD) a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today...

Jan 26, 2016, 07:00 ET

Relmada Therapeutics Files Amended Complaint Against Laidlaw and Its Principals, Matthew Eitner and James Ahern

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the treatment...

Jan 11, 2016, 08:00 ET
Relmada Therapeutics Corporate Logo

Relmada Therapeutics Selected to Present at 2016 Biotech Showcase™ in San Francisco

 Relmada Therapeutics, Inc. (OTCQB: RLMD) a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Jan 04, 2016, 08:00 ET
Relmada Therapeutics Corporate Logo

Relmada Therapeutics Successfully Completes Multiple Ascending Dose Study of d-Methadone for Neuropathic Pain

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company), a clinical-stage company developing novel therapies for the treatment of...

Dec 30, 2015, 11:55 ET

Relmada Therapeutics Announces Results of Annual Meeting of Stockholders

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or "the Company"), a clinical-stage company developing novel therapies for the treatment...

Dec 28, 2015, 08:30 ET

Relmada Therapeutics Recommends Stockholders Vote "FOR" Relmada's Director Nominees on the WHITE Proxy Card Today

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the treatment...

Dec 23, 2015, 08:30 ET

U.S. Federal Court Grants Preliminary Injunction Against Laidlaw & Company and its Principals Matthew Eitner and James Ahern

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the treatment...

Dec 21, 2015, 08:00 ET

Relmada Sends Letter To Stockholders Highlighting Significant Progress In Value Creation Strategy Overseen By Board And Management Team

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the treatment...

Dec 15, 2015, 08:30 ET

Leading Independent Proxy Advisory Firm Glass Lewis Recommends Relmada Stockholders Vote the WHITE Proxy Card "FOR" Relmada's Director Nominees: Shreeram Agharkar and Maged Shenouda

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the treatment...

Dec 14, 2015, 08:30 ET

Pharmaceutical Industry Leader James Dolan Joins Relmada Therapeutics Advisory Team

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the...

Dec 11, 2015, 09:15 ET

U.S. Federal Court Issues Temporary Restraining Order Against Laidlaw & Company and its Principals Matthew Eitner and James Ahern

Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the treatment of...

Dec 10, 2015, 08:00 ET

Relmada Therapeutics Announces Additional Information Regarding Positive Topline Results for Proof-of-Concept Study with BuTab

 Relmada Therapeutics, Inc. (OTCQB: RLMD) a clinical-stage company developing novel therapies for the treatment of chronic pain, today...

Dec 09, 2015, 16:15 ET

Relmada Therapeutics Announces Positive Topline Results for Proof-of-Concept Study with BuTab

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, today...

Dec 09, 2015, 09:26 ET

Relmada Therapeutics Files Federal Lawsuit Against Laidlaw & Company and its Principals Matthew Eitner and James Ahern to Protect Interests of Relmada Stockholders

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the treatment...

Dec 07, 2015, 07:45 ET

Relmada Therapeutics to Mail Letter to Stockholders Highlighting Laidlaw & Company's Questionable Business Practices and Conduct

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), a clinical-stage company developing novel therapies for the treatment...

Dec 01, 2015, 09:24 ET
Relmada Therapeutics Corporate Logo

Relmada Therapeutics to Present at LD Micro Main Event

Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today...

Nov 12, 2015, 08:00 ET
Relmada Therapeutics Corporate Logo

Relmada Therapeutics Strengthens its Board of Directors with the Appointment of Maged Shenouda and Paul Kelly

Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced...

Nov 05, 2015, 08:12 ET
Relmada Therapeutics Corporate Logo

Relmada Therapeutics Responds to 13D Filing by Laidlaw

Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, today issued the...

Oct 13, 2015, 08:00 ET
Relmada Therapeutics Corporate Logo

Relmada Therapeutics to Present at 14th Annual BIO Investor Forum

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain,...

Oct 05, 2015, 08:00 ET
Relmada Therapeutics Corporate Logo

Relmada Therapeutics Announces Management Promotions

Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today...